Literature DB >> 29691705

Retinal dysfunction in a presymptomatic patient with Huntington's disease.

Jonelle Knapp1, Dean A VanNasdale2, Keith Ramsey2, Julie Racine3.   

Abstract

PURPOSE: Huntington's disease (HD) is an autosomal dominant, neurodegenerative disorder characterized by progressive motor dysfunction, cognitive decline, and psychiatric disturbances. Studies have shown retinal abnormalities in patients and mouse models with HD; however, to our knowledge, no prior research papers evaluated retinal structure and function in a presymptomatic patient with HD. The aim of this report is to present a case of retinal dysfunction in a presymptomatic patient with HD.
METHODS: We investigated retinal structure and function in a 25-year-old male who tested positive for the gene that causes HD, but did not have any symptoms normally associated with HD. Vision and ocular testing included a comprehensive dilated ophthalmic examination, 24-2 full-threshold Humphrey visual field, spectral-domain optical coherence tomography (SD-OCT), fundus photography, full-field electroretinogram (ERG), and multifocal electroretinogram (mfERG).
RESULTS: Visual electrophysiology testing showed rod and cone functional anomalies in both eyes. Full-field ERG amplitudes were subnormal in both eyes for the dark-adapted (DA) 0.01 ERG, DA 3 ERG, DA 3 oscillatory potentials (OPs), DA 10 ERG, light-adapted (LA) 3 ERG, and LA 30 Hz flicker, but peak times for the six standard ERG responses were not significantly different from normals. mfERGs revealed functional anomalies of the central retina with attenuated P1 amplitudes for five of the six concentric rings in the right eye and all six rings in the left eye. mfERG P1 peak times were normal at all eccentricities. Dilated fundus examination, SD-OCT, and fundus photography were unremarkable in both eyes. The visual field was normal in the right eye, but there was a mild paracentral field defect in the left eye.
CONCLUSIONS: Our results illustrate that the ERG and mfERG detected early retinal dysfunction in a presymptomatic patient with HD consistent with electroretinogram findings in animal models of HD. However, our report was limited to one patient and additional studies are needed to verify whether the ERG and/or mfERG can uncover neural dysfunction before motor, behavioral, and cognitive abnormalities are discernible in patients with HD.

Entities:  

Keywords:  Electroretinogram; Huntington’s disease; Multifocal electroretinogram; Retinal dysfunction

Mesh:

Year:  2018        PMID: 29691705     DOI: 10.1007/s10633-018-9632-3

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  20 in total

1.  Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice.

Authors:  Dominique Helmlinger; Gaël Yvert; Serge Picaud; Karine Merienne; José Sahel; Jean-Louis Mandel; Didier Devys
Journal:  Hum Mol Genet       Date:  2002-12-15       Impact factor: 6.150

2.  Is the retina affected in Huntington disease?

Authors:  Elisabeth Petrasch-Parwez; Carsten Saft; Annegrit Schlichting; Jürgen Andrich; Markus Napirei; Larissa Arning; Stefan Wieczorek; Rolf Dermietzel; Jörg Thomas Epplen
Journal:  Acta Neuropathol       Date:  2005-10-13       Impact factor: 17.088

Review 3.  ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition).

Authors:  Donald C Hood; Michael Bach; Mitchell Brigell; David Keating; Mineo Kondo; Jonathan S Lyons; Michael F Marmor; Daphne L McCulloch; Anja M Palmowski-Wolfe
Journal:  Doc Ophthalmol       Date:  2011-10-30       Impact factor: 2.379

Review 4.  Huntington disease: pathogenesis and treatment.

Authors:  Praveen Dayalu; Roger L Albin
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

Review 5.  Huntington's disease: from molecular pathogenesis to clinical treatment.

Authors:  Christopher A Ross; Sarah J Tabrizi
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

6.  Acute effects of cigarette smoking on multifocal electroretinogram.

Authors:  Fatih C Gundogan; Cuneyt Erdurman; Ali H Durukan; Gungor Sobaci; M Zeki Bayraktar
Journal:  Clin Exp Ophthalmol       Date:  2007 Jan-Feb       Impact factor: 4.207

7.  A novel function of Huntingtin in the cilium and retinal ciliopathy in Huntington's disease mice.

Authors:  Alice Karam; Lars Tebbe; Chantal Weber; Nadia Messaddeq; Laurette Morlé; Pascal Kessler; Uwe Wolfrum; Yvon Trottier
Journal:  Neurobiol Dis       Date:  2015-05-16       Impact factor: 5.996

8.  Optical coherence tomography findings in Huntington's disease: a potential biomarker of disease progression.

Authors:  Hannah M Kersten; Helen V Danesh-Meyer; Dean H Kilfoyle; Richard H Roxburgh
Journal:  J Neurol       Date:  2015-08-02       Impact factor: 4.849

9.  Enhanced retinal responses in Huntington's disease patients.

Authors:  Jocelynn R Pearl; Laura M Heath; Dani E Bergey; John P Kelly; Corrie Smith; Mercy Y Laurino; Avery Weiss; Nathan D Price; Albert LaSpada; Thomas D Bird; Suman Jayadev
Journal:  J Huntingtons Dis       Date:  2017

10.  Intravitreal administration of HA-1077, a ROCK inhibitor, improves retinal function in a mouse model of huntington disease.

Authors:  Mei Li; Douglas Yasumura; Aye Aye K Ma; Michael T Matthes; Haidong Yang; Gregory Nielson; Yong Huang; Francis C Szoka; Matthew M Lavail; Marc I Diamond
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

View more
  4 in total

1.  Structural Abnormalities of the Optic Nerve and Retina in Huntington's Disease Pre-Clinical and Clinical Settings.

Authors:  Iwona Mazur-Michałek; Katarzyna Kowalska; Daniel Zielonka; Marta Leśniczak-Staszak; Paulina Pietras; Witold Szaflarski; Mark Isalan; Michal Mielcarek
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

Review 2.  Systemic manifestation and contribution of peripheral tissues to Huntington's disease pathogenesis.

Authors:  Chia-Lung Chuang; Fabio Demontis
Journal:  Ageing Res Rev       Date:  2021-05-09       Impact factor: 11.788

Review 3.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

Review 4.  Rhodopsin: A Potential Biomarker for Neurodegenerative Diseases.

Authors:  Cameron Lenahan; Rajvee Sanghavi; Lei Huang; John H Zhang
Journal:  Front Neurosci       Date:  2020-04-15       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.